Carly, a patient at Cincinnati Children’s endocrinology department, her first infusion of Tzield, Friday, April 11, 2025, at the Burnet Campus in Cincinnati. Tzield is FDA-approved to delay the onset of insulin-dependent (Stage 3) type 1 diabetes for a specific group of patients with diabetes. Patients must be eight years or older in stage 2.

Proven Results for Managing Pain

Our expert, caring team of doctors, nurse practitioners, and nurses will work together to help manage pain after surgery.